The dichloromethane fraction of Stemona tuberosa Lour inhibits tumor cell growth and induces apoptosis of human medullary thyroid carcinoma cells

Medullary thyroid carcinoma (MTC), a neuroendocrine tumor arising from the thyroid gland, is known to be poorly responsive to conventional chemotherapy. The root of Stemona tuberosa Lour, also called Bai Bu, is a commonly used traditional Chinese anti-tussive medicine. The present study investigated this medicinal herb for the first time with respect to its anticancer activity in human medullary thyroid carcinoma cells. Four extracts of Stemona tuberosa Lour, including the n-hexane fraction, (ST-1), dichloromethane (DCM) fraction, (ST-2), ethyl acetate (EtOAc) fraction, (ST-3), and methanol fraction, (ST-4) were examined for antiproliferative effects in two MTC cell lines. We observed that only the DCM fraction ST-2 inhibited cell growth and viability in a dose-dependent manner. Furthermore, we found that ST-2 also induced the apoptosis of MTC-SK cells. Caspase-3/7 was activated, while caspase-9 was not, implying that at least a caspase-dependent apoptotic pathway was involved in this process. In addition, the multicellular spheroids of MTC-SK were destroyed and the cell morphology was changed by ST-2. Our results show the strong apoptotic effects of the DCM fraction of Stemona tuberosa Lour on human medullary thyroid carcinomas, so suggesting a new candidate for chemotherapy of the so far chemo-resistant medullary thyroid carcinoma.

[1]  P. Shaw,et al.  Quality evaluation of Radix Stemonae through simultaneous quantification of bioactive alkaloids by high-performance liquid chromatography coupled with diode array and evaporative light scattering detectors. , 2007, Biomedical chromatography : BMC.

[2]  H. Greger,et al.  Pyrrolo- and pyridoazepine alkaloids as chemical markers in Stemona species. , 2007, Phytochemistry.

[3]  H. Greger.  Structural Relationships, Distribution and Biological Activities of Stemona Alkaloids , 2006, Planta medica.

[4]  T. Efferth,et al.  Activity of novel plant extracts against medullary thyroid carcinoma cells. , 2004, Anticancer research.

[5]  P. Olive,et al.  Drug and radiation resistance in spheroids: cell contact and kinetics , 1994, Cancer and Metastasis Reviews.

[6]  G. Lin,et al.  Antitussive activity of Stemona alkaloids from Stemona tuberosa. , 2003, Planta medica.

[7]  C. Seger,et al.  Antifungal stilbenoids from Stemona collinsae. , 2002, Journal of natural products.

[8]  A. Mussa,et al.  Treatment of medullary thyroid carcinoma: an update. , 2001, Endocrine-related cancer.

[9]  A. Abbruzzese,et al.  Current approaches and perspectives in the therapy of medullary thyroid carcinoma , 2001, Cancer.

[10]  S. Lowe,et al.  Genetic analysis of chemoresistance in primary murine lymphomas , 2000, Nature Medicine.

[11]  A. Strasser,et al.  Apoptosis signaling. , 2000, Annual review of biochemistry.

[12]  C Eng,et al.  The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. , 1996, JAMA.

[13]  E. Ingolič,et al.  New continuous cell-line from human medullary-thyroid carcinoma - sinj - phenotypic analysis and invivo carcinogenesis. , 1993, International journal of oncology.

[14]  H. Höfler,et al.  Establishment and characterization of continuous cell line MTC-SK derived from a human medullary thyroid carcinoma. , 1990, Cancer research.